Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
January 02, 2025 16:05 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately $24.3...
Contract Pharmaceutical Dose Manufacturing Industry Research: Composition, Size, Market Share and Outlook for GLP-1 Receptor Agonist Products
December 23, 2024 10:18 ET
|
Research and Markets
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition" report has been added to ...
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
December 19, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
December 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and...
Global CMO/CDMO Market to Reach USD 38.87 Billion by 2032, Driven by Rising Demand for Outsourced Drug Manufacturing | Research by SNS Insider
December 12, 2024 08:00 ET
|
SNS Insider pvt ltd
Austin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- CMO/CDMO Market Size Analysis: “According to SNS Insider, the CMO/CDMO Market reached USD 23.32 billion in 2023 and is anticipated to grow up to USD 38.87...
Peptide and Oligonucleotide CDMO Market Trends and Growth Opportunities to 2030: Industry Forecast to Reach $5 Billion
December 12, 2024 04:17 ET
|
Research and Markets
Dublin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The "Peptide and Oligonucleotide CDMO Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
December 10, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035 - IgG1 Antibody Isotype Segment is Likely to Dominate the ADC Contract Manufacturing Market During the Forecast Period
December 02, 2024 05:09 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody...
Fill Finish Pharmaceutical Contract Manufacturing Market Trends and Global Forecasts, 2024-2035: Growing Drug Pipelines Catalyze Expansion of Pharmaceutical Fill-Finish Contract Manufacturing
December 02, 2024 04:15 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service...